IFNG and cancer: As shown in Fig. 8, after T cells are activated, the expression of immune checkpoints including PD-1 and CTLA-4 increases, and then T cells are able to enter the cancer tissues, causing the cancer tissues to release large amounts of cytokines such as IFN-γ and ultimately resulting in increased expression of immune checkpoints.